ALS reports cyber security incident impacting operations

ALS discloses a cyber security breach affecting operations; most systems are restored as investigations continue.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ALS Ltd (ASX: ALQ) share price is in focus today after the company reported a recent cyber security incident that temporarily disrupted some of its global operations.

Cybersecurity professional man inspects server room and works on iPad.

Image source: Getty Images

What did ALS report?

  • Identified malicious cyber activity with unauthorised third-party access to certain IT systems
  • Temporary disruption occurred in parts of operations, but vast majority now operational
  • Containment and remediation underway with the support of external cyber response experts
  • Australian Cyber Security Centre and other relevant bodies notified
  • Investigation ongoing to determine extent and impact on data

What else do investors need to know?

ALS moved quickly after detecting the breach, working alongside external cyber security specialists to minimise risk and restore services. The company says most operations are now back online, with targeted efforts continuing where needed.

Continuous updates will be provided for clients, government agencies, and stakeholders as the investigation unfolds. ALS is cooperating fully with authorities and remains committed to transparency throughout the process.

What's next for ALS?

ALS says it is focused on fully understanding the incident's impact and strengthening its cyber defences. The company is working towards comprehensive remediation in affected areas and will keep stakeholders informed as efforts progress.

Ongoing investment in IT security and incident response protocols remains a priority to protect client and company data. Investors can expect further updates as more details emerge from the investigation.

ALS share price snapshot

Over the past 12 months, ALS shares have risen 25%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 7% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Healthcare Shares

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Broker Notes

Down 28% in a year, should I buy the dip on Resmed shares right now?

A leading analyst provides his outlook for the beaten-down ResMed share price.

Read more »

A businessman points to an arrow going up on a graph, indicating a share price rise for an ASX company.
Broker Notes

Up 1,277% in a year, why 4DMedical shares are tipped for more outsized gains

A leading analyst forecasts more outperformance from 4DMedical’s rocketing shares. But why?

Read more »

A person bounces another up high from a seesaw as the one in the air looks through a telescope into the future.
Healthcare Shares

Has the CSL share price finally bottomed out?

Is this beaten-down ASX healthcare giant finally turning a corner?

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Healthcare Shares

Why everyone selling Cochlear shares right now could regret it in 3 years

Cochlear shares are down 65%. Here's why investors selling up right now could look back and wish they'd done the…

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Healthcare Shares

Here's what brokers tip for CSL shares over the next 12 months

The beaten-down biotech company's shares are still falling.

Read more »

three excited doctors with hands in the air
Healthcare Shares

Pro Medicus announces $16m US contract renewal

Pro Medicus secures a major US contract renewal, strengthening its US footprint and underlining continued client retention.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

How much higher could Pro Medicus shares go? 2 brokers weigh in

New contract wins and a positive take on AI are tailwinds for this company.

Read more »

A bored man sits at his desk, flat after seeing the latest news on the share market.
Healthcare Shares

Why did CSL shares crash 22% in May?

Things went from bad to worse for this fallen giant last month.

Read more »